AMENDMENT No. 5, dated as of March 11, 2019 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma USA, Inc., a Delaware corporation (the “Borrower”), Horizon Pharma Public Limited Company, an Irish public...Credit Agreement • March 11th, 2019 • Horizon Pharma PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, and as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 2018, this “Agreement”), among HORIZON PHARMA USA, INC., a Delaware corporation (“Horizon” or the “BorrowerHPUI”), HORIZON PHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (“Irish Holdco”), HORIZON PHARMA USA, INC., a Delaware corporation (“HPUI”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
